BE-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BE-101, covering 2025-10-20 to 2025-10-20. Get the full timeline:
Most recent: Clinical Trial Update: BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B [Phase 1, Phase 2]